ANRO·02157Q109·US·equity·Healthcare - Biotechnology-13D/G
ANRO (Alto Neuroscience, Inc.) is held by 59 institutional investors as of Q4 2025. Largest holders: Point72 Asset Management, L.P. ($28.6M), VANGUARD GROUP INC ($24.3M), FRANKLIN RESOURCES INC ($19.9M). Net institutional sentiment: Bullish.
See how ANRO's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer